Volume 20, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Earlier observations, in vitro, demonstrated that the ability of 4,4′-diaminodiphenylsulfone (DDS) to inhibit the glucose utilization of intraerythrocytic is antagonized by elevation of medium glucose levels. In this study we observed that a single oral dose of DDS (100 mg per kg) was less effective in depressing malaria infections in chronically hyperglycemic mice (blood-glucose levels of about 1,000 mg %) than in normoglycemic mice. Unparasitized normoglycemic and diabetic mice possess similar whole-blood DDS levels during the 24 hr after oral dosage with 100 mg per kg of DDS. After treatment of normoglycemic, -infected rats with a single oral dose of DDS (100 mg per kg), the parasitized blood cells removed from these animals 6 hours later consumed less glucose than identically parasitized cells from untreated rats. These observations support the possibility that DDS exerts a portion of its antimalarial activity in vivo through inhibition of utilization of intraerythrocytic parasite glucose.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error